Literature DB >> 20667039

Ambient overnight hold of whole blood prior to the manufacture of blood components.

Stephen Thomas1.   

Abstract

Blood services routinely separate whole blood into components that are then stored under different conditions. The storage conditions used for whole blood prior to separation must therefore be a compromise between the needs of the red cells (which benefit from refrigeration) and plasma and platelets (which are better preserved at ambient temperature). For many years, the approach has been to manufacture plasma and platelet components on the day of blood collection, and to refrigerate any unprocessed blood for manufacture into red cell components on the following day. However, this can make it challenging to maintain adequate stocks of all components. The European practice of 'ambient hold' of whole blood for up to 24 hours prior to processing allows greater flexibility in blood component manufacture, and the data reviewed suggest there is relatively little impact on the quality of red cell or plasma components, and an improvement in the quality of platelet components.
© 2010 The Author. Transfusion Medicine © 2010 British Blood Transfusion Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20667039     DOI: 10.1111/j.1365-3148.2010.01025.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  4 in total

1.  Comparison of quality of red blood cells made from whole blood (after 8 and 24 hours holding time at 2-6 °C and 20-24 °C) in Iran.

Authors:  Azadeh Omidkhoda; Sedigheh Amini Kafi Abad
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

2.  Platelet concentrates prepared after a 20- to 24-hour hold of the whole blood at 22°C.

Authors:  Sherrill J Slichter; Jill Corson; Mary Kay Jones; Todd Christoffel; Esther Pellham; Doug Bolgiano
Journal:  Transfusion       Date:  2012-02-10       Impact factor: 3.157

3.  Effects of whole blood storage in a polyolefin blood bag on platelets for acute normovolemic hemodilution.

Authors:  Yutaka Murata; Eriko Kusudo; Shuji Kawamoto; Kazuhiko Fukuda
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

4.  Process improvement by eliminating mixing of whole blood units after an overnight hold prior to component production using the buffy coat method.

Authors:  Cherie Mastronardi; Peter Schubert; Elena Levin; Varsha Bhakta; Qi-Long Yi; Adele Hansen; Tamiko Stewart; Craig Jenkins; Wanda Lefresne; William Sheffield; Jason P Acker
Journal:  J Blood Transfus       Date:  2013-06-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.